Literature DB >> 8968688

Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India.

M Rema1, M Ponnaiya, V Mohan.   

Abstract

A cohort of 6792 NIDDM patients attending a diabetes centre at Madras in South India was screened using a combination of retinal photography and clinical examination by retinal specialists. A total of 2319 patients (34.1%) had evidence of retinopathy. This included 2090 patients (30.8%) with non-proliferative diabetic retinopathy including 435 patients (6.4%) with maculopathy and 229 patients (3.4%) with proliferative diabetic retinopathy. Multiple logistic regression analyses showed that duration of diabetes, glycosylated haemoglobin, type of treatment (insulin treatment versus non-insulin treatment), systolic and diastolic blood pressures and serum creatinine, showed a positive association with retinopathy while body mass index (BMI) showed an inverse association. The prevalence rates of retinopathy in Southern Indians are comparable to those seen in Europeans. However in view of the high prevalence of diabetes in the Indian sub-continent, diabetic retinopathy could become a formidable challenge in the future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968688     DOI: 10.1016/s0168-8227(96)01327-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  25 in total

1.  Prevalence of Diabetic Retinopathy in Western Indian Type 2 Diabetic Population: A Hospital - based Cross - Sectional Study.

Authors:  Piyush Rameshchandra Ramavat; Manish Rameshchandra Ramavat; Balaji Wasudeo Ghugare; Rohini G Vaishnav; Manjiri Uttam Joshi
Journal:  J Clin Diagn Res       Date:  2013-06-01

Review 2.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.

Authors:  R Pradeepa; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

3.  Population based assessment of diabetic retinopathy in an urban population in southern India.

Authors:  L Dandona; R Dandona; T J Naduvilath; C A McCarty; G N Rao
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

4.  Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India.

Authors:  V Mohan; R Meera; G Premalatha; R Deepa; P Miranda; M Rema
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

5.  Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in South India.

Authors:  M Rema; R Deepa; V Mohan
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

6.  The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.

Authors:  Tasanee S T Smith; John Szetu; Rupert R A Bourne
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

7.  Prevalence and determinants of diabetic retinopathy in Al hasa region of saudi arabia: primary health care centre based cross-sectional survey, 2007-2009.

Authors:  Ataur Rahman Khan; Jill A Wiseberg; Zaki Al Abdul Lateef; Shabbir Ahmad Khan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

8.  Diabetic retinopathy in Oman: a hospital based study.

Authors:  R Khandekar; J Al Lawatii; A J Mohammed; A Al Raisi
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

9.  Diabetic retinopathy among self reported diabetics in southern India: a population based assessment.

Authors:  V Narendran; R K John; A Raghuram; R D Ravindran; P K Nirmalan; R D Thulasiraj
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 10.  The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes.

Authors:  R M Anjana; M K Ali; R Pradeepa; M Deepa; M Datta; R Unnikrishnan; M Rema; V Mohan
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.